Cytokines such as tumor necrosis factor (TNF) are expressed at high levels in rheumatoid
joint tissue, where they contribute significantly to inflammation and articular destruction. TNF …

OBJECTIVES: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with
increasing disability, reduced quality of life and substantial costs (as a result of both …

Rheumatoid arthritis (RA) remains a major clinical problem, but treatments involving
biologics have revolutionized its management. They target pathogenically relevant cytokines …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

Objective To review the cost effectiveness of rheumatoid arthritis (RA) treatments and inform
the clinical recommendations by the European League Against Rheumatism. Methods A …

Background and Objectives Economic evaluations provide information to aid the optimal
utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) …

Objectives. To investigate levels of self-reported adherence to biologic treatment and
establish the contribution of demographic, physical and psychological factors to biologic …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 10th Annual Workshop on Advances in …

Objective. To provide a state of the art of economic analyses applied to rheumatoid arthritis
(RA). Methods. A systematic literature review on economic consequences and …

Background: Long-term control or remission of rheumatoid arthritis (RA) may be possible
with very early treatment. However, no optimal first therapeutic strategy has been …